LeMaitre George W. - 04 Jun 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: LMAT
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 17:29:09 UTC
Prior SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

LeMaitre George W. filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 05 Jun 2026.

Key facts

This page summarizes LeMaitre George W.'s Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
9 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 17:29.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365737 Primary reporting owner

LeMaitre George W

Relationship: Chairman and CEO, Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Gift

Transaction value
Shares: -11,974
Change %: -0.84%
Price: $0.000000^*
Shares after: 1,418,045
Date: 04 Jun 2026
Ownership: Direct

LMAT transaction

Common Stock

Award

Transaction value
Shares: +11,974
Change %: +36%
Price: $0.000000^*
Shares after: 45,374
Date: 04 Jun 2026
Ownership: LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +4
Change %: +8.8%
Price: $0.000000^*
Shares after: 49
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4
Exercise price
Footnotes: F2

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +4
Change %: +9%
Price: $0.000000^*
Shares after: 49
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4
Exercise price
Footnotes: F3

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +7
Change %: +14%
Price: $0.000000^*
Shares after: 57
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7
Exercise price
Footnotes: F4

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +8
Change %: +16%
Price: $0.000000^*
Shares after: 61
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8
Exercise price
Footnotes: F5

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +10
Change %: +23%
Price: $0.000000^*
Shares after: 53
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10
Exercise price
Footnotes: F6

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +11
Change %: +27%
Price: $0.000000^*
Shares after: 54
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11
Exercise price
Footnotes: F7

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +17
Change %: +118%
Price: $0.000000^*
Shares after: 31
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17
Exercise price
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

Footnote F2

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F3

These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F4

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F5

These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F6

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F7

These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F8

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.